Australia

Australia became the world's first nation to reschedule psilocybin and MDMA as Schedule 8 controlled medicines in February 2023, permitting authorised psychiatrists to prescribe psilocybin for treatment-resistant depression and MDMA for PTSD effective July 2023. The Therapeutic Goods Administration (TGA) leads the regulatory framework for these therapies under a tightly supervised Authorised Prescriber scheme.